Peptides for Hollywood Stunt Performers: A Body-Part Look at the Take-Seven Problem
How peptide therapy can support the body through the cumulative load of high-falls, ratchet pulls, fire-gags, and 14-hour shoot days. Walked through the way a stunt performer actually feels the wear: hip, shoulder, skin, metabolic load.

In this article
Key Takeaways
- Stunt performers carry a wear pattern that maps onto specific body regions: the hip and back from repeated high-falls, the shoulder from ratchet pulls and harness drag, the skin from fire-gags and friction, and the metabolic load of 14-hour shoot days.
- Different peptides target different regions: BPC-157 for chronic hip, back, and shoulder load; BPC/TB-500 combo for deeper connective tissue (partial SLAP, labrum, patellar tendinopathy); GHK-Cu injectable for skin barrier and burn recovery; NAD+ for the metabolic side.
- None of these peptides appear on standard SAG-AFTRA production physicals or pre-employment drug panels. They are prescription medications, disclosed like any other Rx.
- Peptide therapy is not a substitute for PRP, stem cell therapy, or surgery. It is continuous low-dose signaling that supports the cumulative wear pattern. The targeted interventions still exist for acute injuries.
Take Seven
The scene
The airbag settled three inches around take four. Your hip flexor started screaming on take six. The AD just called for one more before lunch and the stunt coordinator wants the timing tighter this time. You will get the take. You always get the take. What you will not get is twelve more years like this if you keep absorbing the cumulative load the way you did at 28.
Every working stunt performer past 35 has the conversation in their head. The high-fall pad is not infinite. The ratchet-pull harness leaves a different mark on your shoulder every time. The fire-gag burn cream is a stopgap, not a recovery plan. The chair fight choreography that looked great in rehearsal puts your wrist in a position your wrist does not like.
Why Standard Recovery Does Not Scale
The standard stunt-performer recovery toolkit is built for acute injury. Ice for a flare. The chiro on Burbank Boulevard for an alignment. A Voltaren prescription for the bad days. PRP if something gets flagged on MRI. All of those tools work for what they are designed for. None of them touch the cumulative load.
Cumulative load is the problem of repeated submaximal damage across years. The hip that took ten reps of a high-fall last Tuesday and another six the Tuesday after. The rotator cuff that has absorbed three seasons of fight choreography. The skin that has been exposed to fire-gags, friction, and Arizona summer sun every shoot day for a decade. Acute tools cannot reach that pattern because there is no single acute injury to treat.
Peptide therapy operates on the cumulative side. The molecules work on continuous low-dose signaling: VEGF for new blood vessel growth into damaged tissue, fibroblast modulation for collagen deposition, mitochondrial coenzyme support for cellular energy. None of that fixes an acute tear. All of it shifts how fast the body recovers from the steady wear that defines this job. The rest of this guide walks through the wear region by region.
The Hip and Back
High-fall load goes through the SI joint and the L4-L5 disc. Body-locked takedown drills and stair-gag landings put the same forces through a smaller surface area. The downstream symptoms are familiar: hip flexor tightness, glute medius weakness on the impact side, the lumbar flare that hits on day three of a fall-heavy block.
The damage is in the connective tissue and the disc. Foam rolling and ice address the muscle-pattern symptoms, not the structural source. BPC-157 is the peptide that maps onto this layer. The University of Zagreb has run 100+ preclinical studies on BPC-157 over 30 years, primarily on soft-tissue healing. The mechanism (VEGF upregulation, fibroblast modulation, nitric oxide pathway support) targets exactly what a repeatedly impacted disc and an inflamed SI joint actually need.
Realistic timeline: 2-4 weeks of daily BPC-157 before chronic flare patterns shorten. 6-8 weeks before the cumulative pattern shifts in a noticeable way. BPC-157 will not undo a herniation. What it does is take the edge off the cumulative wear enough that the next fall-heavy block does not feel like the last one.
The Shoulder
Ratchet pull is the classic. Harness drag stunts cause the same load. The forces go through the rotator cuff, the AC joint, and the long head of the biceps. Chronic shoulder impingement is one of the more common career-altering injuries reported by working stunt performers, especially in the late 30s and 40s. SLAP tears and labrum damage are the surgical endpoint when the cumulative load wins.
For deeper connective tissue work, performers typically reach for the BPC-157/TB-500 combo, which ships as a pre-mixed blend in a single vial. BPC-157 sends the repair signals; TB-500 (Thymosin Beta-4) mobilizes cells to the site of injury and supports the actin cytoskeleton dynamics that connective tissue uses to remodel. The combo is what gets used when there is a flagged partial SLAP, a labrum on MRI, or chronic patellar tendinopathy that has been sticking around.
Important boundary: this is not a substitute for surgery when surgery is indicated. A fully torn labrum is a surgical conversation. The combo accelerates the rehab arc when it is the right call to avoid the OR, or supports the post-op rehab when surgery has already happened. The combo is also available as an oral capsule, which is convenient for shoot days when on-location cooler logistics are a hassle.
The Skin
Fire-gags use Nomex underneath and protective gel, but the heat still reaches the skin. Friction from wire harnesses, drag stunts, and stair gags abrades skin daily. Outdoor shoots in Arizona summer or Vancouver winter add UV and cold damage. Barrier integrity is the difference between ready Monday and visible scarring on camera.
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper Complex) is the peptide that targets this layer. It has been in topical skincare for 40 years; the injectable form is the deeper version for serious skin work. It modulates over 4,000 human genes, including a broad set of skin-repair and barrier-function pathways. The dermatology literature on copper peptides for skin repair is well-developed.
For stunt performers, the practical use cases are fire-gag minor burns, friction abrasion from harness work, sun and wind damage on long location shoots, and post-procedure skin recovery (cosmetic work is common in this industry). A common cadence is GHK-Cu daily during heavy production with skin exposure, tapering to 3x weekly during off-cycles.
The Metabolic Load
The metabolic side is what wears down the body's ability to recover from the physical side. 14-hour days. Craft service. Location adrenaline cycles. Sleep on a trailer cot. Cortisol stays elevated for weeks at a stretch. Week three of a production feels different from week one because the metabolic baseline has shifted, not because the physical demand changed.
NAD+ is the coenzyme every cell uses to convert food into ATP. Tissue levels drop with age and with chronic stress load. Injectable NAD+ bypasses the GI conversion limits that cap how much oral NMN and NR can actually raise tissue NAD+. The mechanism is supporting the NAD+/NADH ratio that drives cellular energy production and DNA repair.
Practical use: 2-3x weekly during production, with a higher dose at the start of a long shoot stretch. Anecdotally, NAD+ is the peptide performers report most often as feeling a difference from. The 4 p.m. fade on a long shoot day becomes manageable. Recovery between shoot days starts to keep up with the demand.
What This Is Not
Peptide therapy gets confused with several other things that look adjacent. Four important distinctions:
Not PRP or stem cell therapy. PRP and stem cells deliver concentrated repair signals to a single injury site in one shot, often guided by ultrasound. Peptides are continuous low-dose signaling across the body. Many performers run both: peptides for daily cumulative load, PRP for a specific injury that needs targeted intervention. They complement; they do not substitute.
Not anabolic steroids. These molecules do not increase testosterone, do not grow muscle, do not change physique. BPC-157, TB-500, GHK-Cu, and NAD+ are repair-signaling molecules. The category they sit in is closer to a dermatologist's tretinoin or a sports doctor's compounded NSAID cream than to anything from the steroid family.
Not a substitute for surgery. A fully torn labrum, a complete ACL tear, a flagged tendon rupture: these are surgical conversations. The BPC/TB-500 combo accelerates rehab. It does not reattach tissue. If imaging flags something that needs the OR, the OR is the right answer; peptides go in afterward to support recovery.
Not a painkiller. BPC-157 will not mask pain so you can push through a take that your body is telling you to skip. Do not dose it that way. The repair signaling works on weeks-to-months timescales, not on the take-seven timeline.
Questions From Working Stunt People
Related Guides
Continue reading about peptides and protocols that pair well with this guide.
Pinealon, PE-22-28 & Selank Guide (2026)
Three peptides, three layers of brain support. Pinealon restores sleep architecture through pineal gland regulation. PE-22-28 drives neurogenesis by blocking the TREK-1 potassium channel. Selank calms anxiety through GABA modulation without sedation or dependence. Together they rebuild, grow, and protect neural tissue from three independent angles.
Is CJC-1295/Ipamorelin FDA Approved? (2026 Answer)
The short answer is no. CJC-1295 and Ipamorelin are not FDA-approved drugs. They are compounded medications, prescribed by licensed providers and prepared by regulated pharmacies. Here is what that actually means for you, how it compares to FDA-approved peptides, and why the distinction matters less than most people think.
Is Sermorelin FDA Approved? Yes Until 2008 (Then What?)
Sermorelin has a unique regulatory history. It was FDA-approved in 1997 as Geref Diagnostic for testing pituitary function, and its therapeutic form (Geref) was used for pediatric growth hormone deficiency. Then the manufacturer discontinued it in 2008. Today Sermorelin is only available as a compounded medication. Here is the full story.
Learn more about peptide therapy
Peptide therapy in the US is prescription-only and requires evaluation by a licensed provider. Browse the individual peptides to read about what each one does.